Stockreport

Capricor touts long-term efficacy of DMD therapy ahead of FDA application [Yahoo! Finance]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF data from the Phase II HOPE-2 open-label extension (OLE) trial for its Duchenne muscular dystrophy (DMD) cell therapy, deramiocel. Last week, the company started rolli [Read more]